Amneal Pharmaceuticals (AMRX) Notes Payables: 2018-2024
Historic Notes Payables for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Mar 2024 value amounting to $41.9 million.
- Amneal Pharmaceuticals' Notes Payables was N/A to $41.9 million in Q1 2024 from the same period last year, while for Mar 2024 it was $41.9 million, marking a year-over-year change of. This contributed to the annual value of $41.4 million for FY2023, which is 4.38% up from last year.
- As of Q1 2024, Amneal Pharmaceuticals' Notes Payables stood at $41.9 million, which was up 1.08% from $41.4 million recorded in Q4 2023.
- In the past 5 years, Amneal Pharmaceuticals' Notes Payables ranged from a high of $41.9 million in Q1 2024 and a low of $1.0 million during Q1 2020.
- Over the past 3 years, Amneal Pharmaceuticals' median Notes Payables value was $41.0 million (recorded in 2023), while the average stood at $40.9 million.
- Data for Amneal Pharmaceuticals' Notes Payables shows a peak YoY grew of 4.38% (in 2023) over the last 5 years.
- Over the past 4 years, Amneal Pharmaceuticals' Notes Payables (Quarterly) stood at $1.0 million in 2020, then reached $39.7 million in 2022, then climbed by 4.38% to $41.4 million in 2023, then reached $41.9 million in 2024.
- Its Notes Payables was $41.9 million in Q1 2024, compared to $41.4 million in Q4 2023 and $41.0 million in Q3 2023.